MedTrace Logo

Comparison Efficacy of 14-day Triple Therapy: Clarithromycin vs. Levofloxacin on Eradication of H. Pylori

NCT02693574 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2017-03-21

No results posted yet for this study

Summary

Comparison Efficacy of 14-day Triple Therapy between Clarithromycin and levofloxacin on the Eradication of Helicobacter Pylori in Syrian population

Conditions

  • Helicobacter Pylori Gastrointestinal Tract Infection

Interventions

DRUG

Clarithromycin

DRUG

Levofloxacin

Sponsors & Collaborators

  • UNIPHARMA. Universal Pharmaceutical Industries

    collaborator UNKNOWN

  • Ibn Alhaytham Pharma. Industries Co

    collaborator UNKNOWN

  • Damascus Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-01
Primary Completion
2017-01-28
Completion
2017-05-31

Countries

  • Syria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02693574 on ClinicalTrials.gov